NCT03239080View on ClinicalTrials.gov

Effect of Denosumab in Erosion Healing in RA

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 19, 2017

Primary Completion Date

May 24, 2020

Study Completion Date

May 24, 2020

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Denosumab

Subcutaneous injections of denosumab 60mg will be given in 4 doses at each visit (at baseline, 6, 12 and 18 months).

OTHER

Placebo

Subcutaneous injections of placebo (0.9% Sodium Chloride solution) will be given in 4 doses at each visit (at baseline, 6, 12 and 18 months).

Trial Locations (1)

Unknown

Department of Medicine and Therapeutics, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT03239080 - Effect of Denosumab in Erosion Healing in RA | Biotech Hunter | Biotech Hunter